Leading science, pioneering therapies
CRM Publications

Cell lineage tracing reveals a biliary origin of intrahepatic cholangiocarcinoma.

TitleCell lineage tracing reveals a biliary origin of intrahepatic cholangiocarcinoma.
Publication TypeJournal Article
Year of Publication2014
AuthorsGuest RV, Boulter L, Kendall TJ, Minnis-Lyons SE, Walker R, Wigmore SJ, Sansom OJ, Forbes SJ
JournalCancer Res
Volume74
Issue4
Pagination1005-10
Date Published2014 Feb 15
ISSN1538-7445
KeywordsAnimals, Bacterial Proteins, Biliary Tract, Cell Lineage, Cell Tracking, Cell Transformation, Neoplastic, Cholangiocarcinoma, Genes, p53, Genes, Reporter, Hepatocytes, Keratin-19, Liver Neoplasms, Luminescent Proteins, Mice, Mice, Transgenic, Stem Cells
Abstract

Intrahepatic cholangiocarcinoma is a treatment refractory malignancy with a high mortality and an increasing incidence worldwide. Recent studies have observed that activation of Notch and AKT signaling within mature hepatocytes is able to induce the formation of tumors displaying biliary lineage markers, thereby raising the suggestion that it is hepatocytes, rather than cholangiocytes or hepatic progenitor cells that represent the cell of origin of this tumor. Here, we use a cholangiocyte-lineage tracing system to target p53 loss to biliary epithelia and observe the appearance of labeled biliary lineage tumors in response to chronic injury. Consequent to this, upregulation of native functional Notch signaling is observed to occur spontaneously within cholangiocytes and hepatocytes in this model as well as in human intrahepatic cholangiocarcinoma. These data prove that in the context of chronic inflammation and p53 loss, frequent occurrences in human disease, biliary epithelia are a target of transformation and an origin of intrahepatic cholangiocarcinoma.

DOI10.1158/0008-5472.CAN-13-1911
Alternate JournalCancer Res.
PubMed ID24310400
PubMed Central IDPMC3929349
Grant List096048 / / Wellcome Trust / United Kingdom
/ / Medical Research Council / United Kingdom
/ / Wellcome Trust / United Kingdom
/ / Cancer Research UK / United Kingdom
Publication institute
CRM